KEYWORD

NCI

Brittany Morey, associate professor of health, society and behavior in the Joe C. Wen School of Population & Public Health

Link found between sociocultural institutions in ethnic enclaves and resident health

UC Irvine-led study used novel measures in Asian American and Hispanic neighborhoods

Petra Wilder-Smith, Director of Dentistry, Beckman Laser Institute & Medical Clinic. Professor, School of Medicine

An anticancer camera?

Dr. Petra Wilder-Smith’s screening device takes aim at oral lesions

John Chaput

UCI-developed COVID-19 test detects, identifies specific variants with 100% accuracy

RNA-based method advances personalized medicine for improved patient care

UCI assistant professor of medicine receives MERIT grant from National Cancer Institute

Nick Pannunzio, Ph.D., assistant professor of medicine in the Division of Hematology/Oncology at the UCI School of Medicine, has received a Method to Extend Research in Time Award from the National Cancer Institute. The seven-year grant will bring approximately $410,000 annually to fund his study into a particular acute lymphoblastic leukemia subtype called Philadelphia chromosome-like […]

UCI team pioneers cancer treatment that targets bone metastases while sparing bone

New, safer approach using engineered stem cells could reduce need for chemotherapy

Claudia Benavente is awarded a $2.1 million NCI grant to combat childhood bone cancer

Claudia Benavente, an assistant professor of pharmaceutical sciences and developmental & cell biology at UCI, has received a $2.1 million grant from the National Cancer Institute to develop a novel therapeutic treatment for osteosarcoma. Her research aims to explain the role of the chromatin remodeling protein UHRF1 as a potential target in the treatment of […]

School of Medicine research team is awarded $3.4 million Cancer Moonshot initiative grant

UCI School of Medicine researchers have been awarded a $3.4 million grant by the National Cancer Institute as part of the Beau Biden Cancer Moonshot initiative. The funding will support efforts to provide proof of principal data for an entirely new class of cancer-killing immunotherapeutics with the potential to treat highly diverse types of cancer, […]